Subscribe free

HPB & Spleen ·

Accelerated Management Cuts Treatment Times for Pancreatic and Liver Cancer

A streamlined approach to pancreatic and hepatocellular cancer treatment in Scotland significantly slashed the time from diagnosis to definitive treatment. Median treatment initiation for hepatocellular carcinoma (HCC) decreased from 98 to 62 days, while for pancreatic cancer (PC) the timeline shortened from 54 to 38 days. Enhanced communication and centralized oversight under the pathway improvement project led to swift alerts and improved care coordination, expediting critical interventions for nearly 400 patients.

Journal Article by Adair A, Urquhart C and Carter R in Eur J Surg Oncol

Copyright © 2025 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.

read the whole article in Eur J Surg Oncol

open it in PubMed

Summaries are written to help you decide what to read. They do not replace the full paper.

Free · 5 minutes a day

Get every new paper in HPB & Spleen.

Plus the Daily Selection: the five most relevant papers of the day, each cut to its key points.

Specialty newsletters: every new paper in your field, as a list of titles linked to the source. Daily Selection: the five that matter, cut to their key points.

FreeNo spamOne-click unsubscribe

More in HPB & Spleen

The latest stitches

Br J Surg5 Nov 2026

Rectal cancer and liver spread: similar outcomes

Removing the rectal tumor and liver spread in one operation did not clearly raise complications or hurt survival compared with two separate operations, a French national study found.

All papers in HPB & Spleen →